Information  X 
Enter a valid email address

Aberdeen Emerg IncCo (AEMC)

  Print      Mail a friend

Tuesday 13 August, 2019

Aberdeen Emerg IncCo

Portfolio Update

RNS Number : 9371I
Aberdeen Emerging Markets Inv Co Ld
13 August 2019
 

13 August 2019

 

Aberdeen Emerging Markets Investment Company Limited

LEI: 213800RIA1NX8DP4P938

Availability of Portfolio Data on Website

 

 

Aberdeen Emerging Markets Investment Company Limited (the "Company") announces that the unaudited monthly portfolio listing of the Company, as at 31 July 2019, is now available on the Company's website at www.aberdeenemergingmarkets.co.uk.

 

Financial assets have been valued on a fair value basis using bid prices, or, if more appropriate, a last trade basis. In addition, investments in underlying funds for the month end are valued using values (whether final or estimated) as advised by their managers or administrators. The Company has therefore relied on the valuation and reporting methods used by the managers or administrators of the underlying funds.

 

Enquiries:                                                                                        

 

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to Aberdeen Emerging Markets Investment Company Limited)

Colin Edge / William Hemmings

Tel: +44 (0)207 463 5881

           

 

PraxisIFM Fund Services (UK) Limited (UK Administration Agent)

Anthony Lee    Tel: +44 (0)20 7653 9690

 

 

Ordinary Shares - Listing Category: Premium - Equity Closed-ended Investment Funds

 

 

Note: The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the document referred to above, is neither incorporated into nor forms part of the above announcement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PFUBLGDISDBBGCX

a d v e r t i s e m e n t